Trademark: 88620045
Status Date
Monday, July 12, 2021
Filing Date
Tuesday, September 17, 2019
Published for Opposition
Tuesday, April 14, 2020
Abandoned Date
Monday, July 12, 2021
1 Diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagents for scientific use, slides, solid matrix materials, microfluidic devices and instruction manuals
5 Diagnostic test kits for scientific use comprising reagents for medical use, slides, solid matrix materials, microfluidic devices and instruction manuals
10 Diagnostic kits comprising medical instruments for measuring, testing, and analyzing blood, bodily fluids, and tissue
42 Conducting medical research and providing technical support in the nature of computer software support services to other medical researchers in the fields of oncology, pulmonology, hematology, pathology, and medical genetics; conducting clinical trials and supporting other medical and biomedical researchers by providing medical and scientific research in clinical trials in the fields of oncology, pulmonology, hematology, pathology, immunology, and medical genetics; providing software as a service (SaaS)services featuring software for use in medical diagnostics using bioinformatics analysis supporting clinicians and researchers in the fields of oncology, pulmonology, hematology, pathology, immunology, and medical genetics; providing software as a service (SaaS) services featuring software for the analysis of clinical laboratory data, genomics data, and environmental factor data for use in identifying and predicting actionable biomarkers, neoantigens, other molecular data relevant to developing paired diagnostics and therapeutics in the fields of oncology, pulmonology, hematology, pathology, immunology, and medical genetics; providing software as a service (SaaS) services featuring software for executing preconfigured non-field specific machine learning and deep learning algorithms and processes for the purposes of uploading and managing data for the training of preconfigured data models for utilizing said trained data models for use in biomedical research; providing software as a service (SaaS) services featuring software for detecting and predicting significance of neoantigens and peptides on cells relevant to immunotherapy development; providing medical laboratory services and performing medical testing on tissue samples and body fluids for the detection of genetic and genomic information pertaining to human disease for medical research purposes
44 Providing medical services including diagnosis, treatment, and care management in fields of oncology, pulmonology, hematology, pathology, immunology, and medical genetics; performing medical testing on tissue samples and body fluids for the detection of genetic and genomic information pertaining to human disease for diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services and medical testing for diagnostic or treatment purposes of oncology, pulmonology, hematology, pathology, immunology, and medical genetics
Jul 12, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 12, 2021
Abandonment - No Use Statement Filed
Dec 11, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 9, 2020
Extension 1 Granted
Dec 9, 2020
Extension 1 Filed
Dec 9, 2020
Teas Extension Received
Jun 9, 2020
Noa E-Mailed - Sou Required From Applicant
Apr 14, 2020
Official Gazette Publication Confirmation E-Mailed
Apr 14, 2020
Published For Opposition
Mar 25, 2020
Notification Of Notice Of Publication E-Mailed
Mar 9, 2020
Approved For Pub - Principal Register
Mar 9, 2020
Examiner's Amendment Entered
Mar 9, 2020
Notification Of Examiners Amendment E-Mailed
Mar 9, 2020
Examiners Amendment E-Mailed
Mar 9, 2020
Examiners Amendment -Written
Mar 4, 2020
Teas/Email Correspondence Entered
Mar 3, 2020
Correspondence Received In Law Office
Mar 3, 2020
Teas Response To Office Action Received
Mar 2, 2020
Notification Of Non-Final Action E-Mailed
Mar 2, 2020
Non-Final Action E-Mailed
Mar 2, 2020
Non-Final Action Written
Feb 25, 2020
Previous Allowance Count Withdrawn
Feb 18, 2020
Withdrawn From Pub - Og Review Query
Feb 3, 2020
Approved For Pub - Principal Register
Feb 3, 2020
Examiner's Amendment Entered
Feb 3, 2020
Notification Of Examiners Amendment E-Mailed
Feb 3, 2020
Examiners Amendment E-Mailed
Feb 3, 2020
Examiners Amendment -Written
Jan 31, 2020
Teas/Email Correspondence Entered
Jan 30, 2020
Correspondence Received In Law Office
Jan 30, 2020
Teas Response To Office Action Received
Dec 30, 2019
Notification Of Non-Final Action E-Mailed
Dec 30, 2019
Non-Final Action E-Mailed
Dec 30, 2019
Non-Final Action Written
Dec 17, 2019
Assigned To Examiner
Sep 25, 2019
New Application Office Supplied Data Entered In Tram
Sep 20, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
